The experiments demonstrated that transmembrane TNF-TNFR2 signaling upregulated the expression of Cxcl1 in tumor cells and cancer-associated fibroblasts (CAFs), leading to increased pro-inflammatory signaling. The gene discussed is CXCL1; the disease is cancer.